NCT03534830View on ClinicalTrials.gov

A Novel Assay for Predicting Surgical Outcomes in Pelvic Organ Prolapse

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

February 2, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

January 1, 2021

Conditions
Prolapse Genital
Interventions
DIAGNOSTIC_TEST

MRI

pre-operative MRI to be performed on all patients and then based on the imaging studies, the patient will be divided into the two comparative cohorts

Trial Locations (1)

33606

University of South Florida, Tampa

All Listed Sponsors
lead

University of South Florida

OTHER

NCT03534830 - A Novel Assay for Predicting Surgical Outcomes in Pelvic Organ Prolapse | Biotech Hunter | Biotech Hunter